精华制药(002349.SZ)：上半年净利润1.31亿元 同比下降3.54%

Core Insights - Jinghua Pharmaceutical (002349.SZ) reported a revenue of 731 million yuan for the first half of 2025, representing a year-on-year growth of 1.54% [1] - The net profit attributable to shareholders decreased by 3.54% year-on-year to 131 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 127 million yuan, down 1.14% year-on-year [1] - Basic earnings per share stood at 0.1605 yuan [1]